Inês Bártolo graduated in Microbiology and Genetics from the Faculdade de Ciências da Universidade de Lisboa. In 2005, she completed an MS degree in Emerging Infectious Diseases from the Faculdade de Medicina da Universidade de Lisboa. Inês obtained her Ph.D. degree in Pharmacy (Microbiology) from the Faculdade de Farmácia da Universidade de Lisboa., in November 2011. Since March 2019, she has held a Junior Investigator position at HIV Evolution, Epidemiology and Prevention Group, iMed.Ulisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal. Her main research interests are the search for new compounds with anti-HIV activity and with activity against several RNA respiratory viruses, including SARS-Cov-2. Another area of interest relies on the characterization of HIV-1 diversity and investigation of the origin and epidemiological history of HIV-1 in Portugal and Portuguese Speaking African Countries and the study of the impact of genetic diversity and molecular epidemiology of HIV-1 infection in diagnosis, disease progression, and susceptibility to antiretroviral therapy.
She has published 31 articles in international journals with peer review. She has presented 73 communications at scientific meetings and received several awards, grants, and distinctions.
Research Keywords & Expertise
Drug Resistance
HIV (human immunodefic...
New Drug Development
Fingerprints
13%
Drug Resistance
Short Biography
Inês Bártolo graduated in Microbiology and Genetics from the Faculdade de Ciências da Universidade de Lisboa. In 2005, she completed an MS degree in Emerging Infectious Diseases from the Faculdade de Medicina da Universidade de Lisboa. Inês obtained her Ph.D. degree in Pharmacy (Microbiology) from the Faculdade de Farmácia da Universidade de Lisboa., in November 2011. Since March 2019, she has held a Junior Investigator position at HIV Evolution, Epidemiology and Prevention Group, iMed.Ulisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal. Her main research interests are the search for new compounds with anti-HIV activity and with activity against several RNA respiratory viruses, including SARS-Cov-2. Another area of interest relies on the characterization of HIV-1 diversity and investigation of the origin and epidemiological history of HIV-1 in Portugal and Portuguese Speaking African Countries and the study of the impact of genetic diversity and molecular epidemiology of HIV-1 infection in diagnosis, disease progression, and susceptibility to antiretroviral therapy.
She has published 31 articles in international journals with peer review. She has presented 73 communications at scientific meetings and received several awards, grants, and distinctions.